Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01678391
Other study ID # 2012.065-1
Secondary ID
Status Completed
Phase N/A
First received August 29, 2012
Last updated July 25, 2016
Start date August 2012
Est. completion date March 2016

Study information

Verified date July 2016
Source California Pacific Medical Center Research Institute
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

To assess the feasibility and success of endoscopic ultrasound (EUS) directed biliary stone removal without use of fluoroscopy. Success for this study will be defined as the successful removal of all stones from the bile duct without the use of fluoroscopy. Fluoroscopy will only be used at the end of a presumed successful procedure to confirm that all stones are removed.


Recruitment information / eligibility

Status Completed
Enrollment 33
Est. completion date March 2016
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients able to give informed consent

- Patients referred to IES for the endoscopic evaluation and treatment of suspected bile duct stones

Exclusion Criteria:

- Patients with >3 bile duct stones or with any stone >12mm on EUS

- Patients with no bile duct stones on EUS

- Patients with altered biliary anatomy (periampullary diverticulum, anomalous pancreatibiliary junction, altered surgical anatomy)

- Patients who are pregnant or breast-feeding

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Procedure:
Common bile duct stone removal without fluoroscopy.
ERCP stone extraction technique without fluoroscopy involves: (1) catheter or catheter with wire access into the bile duct, (2) confirmation of biliary access with catheter aspiration of bile, (3) performance of endoscopic biliary sphincterotomy or balloon dilation to widen the bile duct opening to permit stone removal, (4) stone removal - number of stones seen on EUS should match the number removed.

Locations

Country Name City State
United States California Pacific Medical Center San Francisco California

Sponsors (3)

Lead Sponsor Collaborator
California Pacific Medical Center Research Institute Northwestern University, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

References & Publications (3)

Carr-Locke DL. Overview of the role of ERCP in the management of diseases of the biliary tract and the pancreas. Gastrointest Endosc. 2002 Dec;56(6 Suppl):S157-60. Review. — View Citation

Menees S, Elta G. Endoscopic retrograde cholangiopancreatography during pregnancy. Gastrointest Endosc Clin N Am. 2006 Jan;16(1):41-57. Review. — View Citation

Shelton J, Linder JD, Rivera-Alsina ME, Tarnasky PR. Commitment, confirmation, and clearance: new techniques for nonradiation ERCP during pregnancy (with videos). Gastrointest Endosc. 2008 Feb;67(2):364-8. doi: 10.1016/j.gie.2007.09.036. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Successful removal of all stones from the bile duct without the use of fluoroscopy. Up to 24 hours. No
See also
  Status Clinical Trial Phase
Completed NCT02329977 - Rate of Duodenal-biliary Reflux Increases in Patients With Recurrent Common Bile Duct Stones N/A
Recruiting NCT02545153 - Fibrin Sealant for Cholangiotomy Closure Study Phase 2